Table 3.
A: where α = 0.05 (without correction for multiple-testing) | ||
---|---|---|
H2 | TDT | Case-control |
0.02 | 0.121 | 0.464 |
0.05 | 0.231 | 0.849 |
0.10 | 0.403 | 0.989 |
0.20 | 0.669 | 1.000 |
B: where α = 0.001 (with correction for multiple-testing) | ||
H2 | TDT | Case-control |
0.02 | 0.006 | 0.078 |
0.05 | 0.019 | 0.383 |
0.10 | 0.058 | 0.836 |
0.20 | 0.186 | 0.997 |
TDT, transmission disequilibrium test.
The optimal situation is calculated with a K = 0.20 (incidence of nonallergic vasomotor rhinitis in the United States is estimated to be between 20% and 25%) and the minor allele frequency = 0.1. H2 denotes heritability (the proportion of phenotypic variation ascribed to the genetic variability at the putative locus under investigation). The reason for including an H2 of 0.10 and 0.20 is to attain “the highest achievable” statistical power for our small-sample TDT analysis—although such high heritability levels seldom occur in common diseases. Additivity is assumed in these power calculations. These calculations underscore the fact that the power of the TDT analysis is far lower than that of the case-control study.